Hussain, S. A., Lester, J. F., Jackson, R., Gornall, M., Qureshi, M., Elliott, A., Crabb, S. J., Huddart, R. A., Vasudev, N., Birtle, A. J., Worlding, J., James, N. D., Parikh, O., Vilarino-Varela, M., Alonzi, R., Linch, M. D., Riaz, I. B., Catto, J. W. F., Powles, T., & Jones, R. J. (2022). addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. Lancet oncology, 23(5), 650–658. http://access.bl.uk/ark:/81055/vdc_100153806580.0x00000e